Cargando…
“iPSC-derived liver organoids and inherited bleeding disorders: Potential and future perspectives”
The bleeding phenotype of hereditary coagulation disorders is caused by the low or undetectable activity of the proteins involved in hemostasis, due to a broad spectrum of genetic alterations. Most of the affected coagulation factors are produced in the liver. Therefore, two-dimensional (2D) culture...
Autores principales: | Roman, Giacomo, Stavik, Benedicte, Lauritzen, Knut H., Sandset, Per Morten, Harrison, Sean P., Sullivan, Gareth J., Chollet, Maria Eugenia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9880334/ https://www.ncbi.nlm.nih.gov/pubmed/36711019 http://dx.doi.org/10.3389/fphys.2023.1094249 |
Ejemplares similares
-
Merits and challenges of iPSC-derived organoids for clinical applications
por: Xu, Ziran, et al.
Publicado: (2023) -
Advancing Drug Discovery for Neurological Disorders Using iPSC-Derived Neural Organoids
por: Costamagna, Gianluca, et al.
Publicado: (2021) -
iPSC-Derived Organoids as Therapeutic Models in Regenerative Medicine and Oncology
por: Turhan, Ali G., et al.
Publicado: (2021) -
Application of an iPSC‐Derived Organoid Model for Localized Scleroderma Therapy
por: Ma, Jie, et al.
Publicado: (2022) -
iPSC-derived mesenchymal cells that support alveolar organoid development
por: Tamai, Koji, et al.
Publicado: (2022)